Search results for "Intestinal mucosa"

showing 10 items of 373 documents

Morphometrische Untersuchungen an Darminterponaten nach totaler Gastrektomie

1982

Im Tierexperiment wurden nach totaler Gastrektomie die Bildung eines Ersatzmagens mit verschiedenen Darminterponaten sowie der Oesophago-Jejunostomie mit Roux-Y-Anastomose durchgefuhrt. Bei der Relaparotomie nach 3monatiger postoperativer Uberlebenszeit wurden die Interponate an ausgewahlten Stellen morphometrisch untersucht. Als deutlichste Veranderung fiel bei allen Dunndarmersatzmagen eine starke muskulare Wandhypertrophie auf, die vor allem die Ringmuskulatur betraf. Beim Colonersatzmagen, der physiologisch eine dickere Wandmuskulatur besitzt, war die Hypertrophie sehr viel geringer. Als pathogenetischer Faktor dieser Veranderung gilt die Volumenbelastung, der der Ersatzmagen an dieser …

GynecologyJejunal interpositionmedicine.medical_specialtyIntestinal mucosaCardiothoracic surgerybusiness.industrymedicine.medical_treatmentmedicineSurgeryGastrectomybusinessColon interpositionLangenbecks Archiv f�r Chirurgie
researchProduct

Zur Immunpathogenese der chronisch entz�ndlichen Darmerkrankungen

2000

Die chronisch entzundlichen Darmerkrankungen (CED: Morbus Crohn, Colitis ulcerosa) sind durch schubartig verlaufende destruierende Entzundungsreaktionen der Darmschleimhaut gekennzeichnet. In den letzten Jahren konnte gezeigt werden, das bei diesen Erkrankungen eine pathologische Aktivierung des intestinalen Immunsystems durch mucosale Antigene auftritt. In der chronischen Phase der Erkankungen sowie bei der Entwicklung postoperativer Rezidive sind Anderungen in der Zellmigration sowie der Cytokinproduktion intestinaler Zellen wahrscheinlich von entscheidender Bedeutung. Basierend auf diesen neuen pathogenetischen Erkenntnissen werden zur Zeit innovative klinische Behandlungsstrategien gete…

Gynecologymedicine.medical_specialtyTransplant surgeryIntestinal mucosabusiness.industryCrohn diseasemedicineInflammatory Bowel DiseasesSurgerybusinessGenetic therapyDer Chirurg
researchProduct

Comparative analysis of Hsp10 and Hsp90 expression in healthy mucosa and adenocarcinoma of the large bowel.

2014

Heat shock proteins (Hsps) assist other proteins in their folding and drive the degradation of defective proteins. During evolution, these proteins have also acquired other roles. Hsp10 is involved in immunomodulation and tumor progression. Hsp90 stabilizes a range of "client" proteins involved in cell signaling. The present study evaluated the expression levels of Hsp10 and Hsp90 in normal mucosa and adenocarcinoma samples of human large bowel.Samples of normal mucosa and adenocarcinoma were collected and Reverse transcriptase-polymerase chain reaction RT-PCR, western blotting (WB) analyses, as well as immunohistochemistry were performed to evaluate the expression levels of Hsp10 and Hsp90…

Hsp10Reverse Transcriptase Polymerase Chain Reactionlarge bowel adenocarcinomaBlotting WesternColonic NeoplasmsRT-PCRChaperonin 10HumansHsp90HSP90 Heat-Shock ProteinsAdenocarcinomaIntestinal MucosaImmunohistochemistryAnticancer research
researchProduct

Orally based diagnosis of celiac disease:current perspective

2008

Celiac disease (CD) is a lifelong immune-mediated disorder caused by the ingestion of wheat gluten in genetically susceptible persons. Most cases of CD are atypical and remain undiagnosed, which exposes the individuals to the risk of life-threatening complications. Serologic endomysial and tissue transglutaminase antibody tests are used to screen at-risk individuals, although a firm diagnosis requires demonstration of characteristic histopathologic findings in the small-intestinal mucosa. A gluten challenge, with a repeat biopsy to demonstrate recurrence of histopathologic changes in the intestinal mucosa after the re-introduction of gluten, is considered for those persons in whom diagnosi…

Immunoglobulin Aceliac disease diagnosis oral mucosa saliva screeningmedicine.medical_specialtySalivaGlutensDiseaseGastroenterologyAntibodiesSerologyIntestinal mucosaInternal medicinemedicineHumansMass ScreeningOral mucosaSalivaGeneral Dentistrychemistry.chemical_classificationbiologybusiness.industryMouth MucosaGlutenCeliac Diseasemedicine.anatomical_structurechemistryImmunoglobulin A SecretoryImmunologybiology.proteinAntibodybusiness
researchProduct

Interferon-λ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection.

2015

The epithelium is the main entry point for many viruses, but the processes that protect barrier surfaces against viral infections are incompletely understood. Here we identified interleukin 22 (IL-22) produced by innate lymphoid cell group 3 (ILC3) as an amplifier of signaling via interferon-λ (IFN-λ), a synergism needed to curtail the replication of rotavirus, the leading cause of childhood gastroenteritis. Cooperation between the receptor for IL-22 and the receptor for IFN-λ, both of which were 'preferentially' expressed by intestinal epithelial cells (IECs), was required for optimal activation of the transcription factor STAT1 and expression of interferon-stimulated genes (ISGs). These d…

ImmunologyImmunoblottingMolecular Sequence DataGene ExpressionMice Transgenicmedicine.disease_causeRotavirus InfectionsCell LineMadin Darby Canine Kidney CellsInterleukin 22DogsInterferonRotavirusChlorocebus aethiopsmedicineImmunology and AllergyAnimalsHumansSTAT1Intestinal MucosaReceptors CytokineVero CellsMice KnockoutbiologyReverse Transcriptase Polymerase Chain ReactionInterleukinsInnate lymphoid cellInterleukinDrug SynergismEpithelial CellsVirology3. Good healthIntestinesMice Inbred C57BLSTAT1 Transcription FactorViral replicationImmunologybiology.proteinVero cellCytokinesCaco-2 CellsHT29 Cellsmedicine.drugNature immunology
researchProduct

Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation.

1997

The above new findings concerning the immunological mechanisms governing mucosa, immune responses and oral tolerance in TCR-transgenic mice, as well as those operative in mice with experimental colitis, greatly expand our understanding of the processes that normally control mucosal inflammation and possibly other types of inflammation as well (Fig. 1). They indicate that, in the nondiseased mouse, ingested proteins evoke a Th1-cell (IFN-gamma) response in the mucosal follicles that is quickly counter-regulated by induction of T-cell anergy/deletion, if this Th1-cell response is inhibited (experimentally by anti-IL-12), TGF beta-producing cells appear, and these are capable of active immune …

ImmunologyMucosal inflammationGastrointestinal inflammationExperimental colitisBiologyColitisProinflammatory cytokineInterferon-gammaInterferon γTransforming Growth Factor betaImmunologyAnimalsHumansIntestinal MucosaOral toleranceTransforming growth factorImmunology today
researchProduct

In situ kinetic modelling of intestinal efflux in rats: functional characterization of segmental differences and correlation with in vitro results.

2007

The objective was to devise and apply a novel modelling approach to combine segmental in situ rat perfusion data and in vitro cell culture data, in order to elucidate the contribution of efflux in drug absorption kinetics. The fluoroquinolone CNV97100 was used as a model P-gp substrate. In situ intestinal perfusion was performed in rat duodenum, jejunum, ileum and colon to measure the influence of P-gp expression on efflux. Inhibition studies of CNV97100 were performed in the presence of verapamil, quinidine, cyclosporin A and p-aminohippuric acid. Absorption/efflux parameters were modelled simultaneously, using data from both in situ studies as well as in vitro studies. The maximal efflux …

In situAbsorption (pharmacology)MaleColonVasodilator AgentsPharmaceutical ScienceIleumMuscarinic AntagonistsModels BiologicalIntestinal absorptionPermeabilityJejunumCiprofloxacinCyclosporin aIntestine SmallmedicineAnimalsPharmacology (medical)ATP Binding Cassette Transporter Subfamily B Member 1Intestinal MucosaRats WistarP-glycoproteinPharmacologybiologyDose-Response Relationship DrugMolecular StructureChemistryGeneral MedicineQuinidineRatsKineticsmedicine.anatomical_structureBiochemistryIntestinal AbsorptionVerapamilbiology.proteinBiophysicsCyclosporinep-Aminohippuric AcidEffluxAlgorithmsImmunosuppressive AgentsFluoroquinolonesBiopharmaceuticsdrug disposition
researchProduct

In-situ intestinal rat perfusions for human Fabs prediction and BCS permeability class determination: Investigation of the single-pass vs. the Doluis…

2015

Intestinal drug permeability has been recognized as a critical determinant of the fraction dose absorbed, with direct influence on bioavailability, bioequivalence and biowaiver. The purpose of this research was to compare intestinal permeability values obtained by two different intestinal rat perfusion methods: the single-pass intestinal perfusion (SPIP) model and the Doluisio (closed-loop) rat perfusion method. A list of 15 model drugs with different permeability characteristics (low, moderate, and high, as well as passively and actively absorbed) was constructed. We assessed the rat intestinal permeability of these 15 model drugs in both SPIP and the Doluisio methods, and evaluated the co…

In situMaleSingle passIntestinal permeabilitybusiness.industryPharmaceutical ScienceBioequivalencePharmacologymedicine.diseaseBiopharmaceutics Classification SystemModels BiologicalPermeabilityBioavailabilityRatsPerfusionPermeability (earth sciences)Intestinal AbsorptionPharmaceutical PreparationsmedicineAnimalsHumansIntestinal MucosaRats WistarbusinessPerfusionInternational journal of pharmaceutics
researchProduct

Integrating theoretical and experimental permeability estimations for provisional biopharmaceutical classification: Application to the WHO essential …

2018

The accuracy of the provisional estimation of the Biopharmaceutics Classification System (BCS) is heavily influenced by the permeability measurement. In this study, several theoretical and experimental models currently employed for BCS permeability classification have been analysed. The experimental models included the in situ rat intestinal perfusion, the ex vivo rat intestinal tissue in an Ussing chamber, the MDCK and Caco-2 cell monolayers, and the parallel artificial membrane (PAMPA). The theoretical models included the octanol-water partition coefficient and the QSPeR (Quantitative Structure-Permeability Relationship) model recently developed. For model validation, a dataset of 43 comp…

In vitro dissolutionTheoretical modelsPharmaceutical Science02 engineering and technologyBioequivalenceIn Vitro TechniquesWorld Health Organization030226 pharmacology & pharmacyModels BiologicalDosage formPermeabilityBiopharmaceuticsMadin Darby Canine Kidney Cells03 medical and health sciences0302 clinical medicineDogsAnimalsHumansPharmacology (medical)Intestinal MucosaMathematicsPharmacologyGeneral Medicine021001 nanoscience & nanotechnologyBiopharmaceutics Classification SystemBioavailabilityRatsPermeability (earth sciences)BiopharmaceuticalCaco-2 Cells0210 nano-technologyBiological systemDrugs EssentialBiopharmaceuticsdrug disposition
researchProduct

Interleukin-12 and -23 Control Plasticity of CD127(+) Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria.

2015

Human group 1 ILCs consist of at least three phenotypically distinct subsets, including NK cells, CD127(+) ILC1, and intraepithelial CD103(+) ILC1. In inflamed intestinal tissues from Crohn's disease patients, numbers of CD127(+) ILC1 increased at the cost of ILC3. Here we found that differentiation of ILC3 to CD127(+) ILC1 is reversible in vitro and in vivo. CD127(+) ILC1 differentiated to ILC3 in the presence of interleukin-2 (IL-2), IL-23, and IL-1β dependent on the transcription factor RORγt, and this process was enhanced in the presence of retinoic acid. Furthermore, we observed in resection specimen from Crohn's disease patients a higher proportion of CD14(+) dendritic cells (DC), whi…

Interleukin 2Receptors Retinoic AcidCellular differentiationCD14ImmunologyInterleukin-1betaRetinoic acidLipopolysaccharide Receptorschemical and pharmacologic phenomenaTretinoinMice SCIDBiologyInterleukin-12 Subunit p35Interleukin-7 Receptor alpha Subunitchemistry.chemical_compoundMiceIntestinal mucosaCrohn DiseaseMice Inbred NODmedicineImmunology and AllergyAnimalsHumansRetinoid X Receptor gammaLymphocytesIntestinal MucosaInterleukin-7 receptorCells CulturedMice KnockoutRetinoic Acid Receptor alphaInnate lymphoid cellvirus diseaseshemic and immune systemsCell DifferentiationDendritic CellsNuclear Receptor Subfamily 1 Group F Member 3Molecular biologyKiller Cells NaturalMice Inbred C57BLInfectious DiseaseschemistryLymphocyte TransfusionImmunologyInterleukin 12Interleukin-23 Subunit p19Interleukin-2medicine.drugImmunity
researchProduct